Skip to main content

Table 3 Metabolic findings after clinical intervention

From: Aggressive clinical approach to obesity improves metabolic and clinical outcomes and can prevent bariatric surgery: a single center experience

  Baseline After intervention Change
TG (mg/dL) 177.4 81.0 −96.4 (−54.3%; p < 001)
LDL (mg/dL) 118.1 98.8 −19.3 (−26.3%; p < 0.05)
ALT (U/L) 52.9 27.8 −25.1 (−47.4%; p < 0.001)
GGT (mg/dL) 47.8 15.2 −32.6 (−68.2%; p < 0.001)
Basal insulin (μIU/mL) 23.1 7.9 −15.2 (−65.8%; p < 0.001)
Fasting glucose (mg/dL) 91.4 77.5 −13.9 (−15.2%; p < 0.001)
HOMA-IR 5.21 1.51 −3.7 (−70.8%; p < 0.001)
Uric acid (mg/dL) 7.1 5.7 −1.4 (−19.7%; p < 0.001)
CRP (mg/L) 0.73 0.39 −0.34 (−46.6%; p < 0.001)
HbA1c (%) 5.87 5.15 −0.72 (−13.6%; p < 0.001)